메뉴 건너뛰기
Gynecologic Oncology
Volumn 107, Issue 2, 2007, Pages 356-357
CA-125 level preoperative assessment in early and advanced ovarian carcinoma
Author keywords

[No Author keywords available]
Indexed keywords

CA 125 ANTIGEN;
EID: 35348872187     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2007.07.002     Document Type: Letter
Times cited : (3)
References (5)
  • 1
    • 33847003042 scopus 로고    scopus 로고
    • A new prognostic model for FIGO stage 1 epithelial ovarian cancer
    • Obermair A., Fuller A., Lopez-Varela E., et al. A new prognostic model for FIGO stage 1 epithelial ovarian cancer. Gynecol Oncol 104 (2007) 607-611
    • (2007) Gynecol Oncol , vol.104 , pp. 607-611
    • Obermair, A.1    Fuller, A.2    Lopez-Varela, E.3
  • 2
    • 33646342757 scopus 로고    scopus 로고
    • COX-2 and preoperative CA-125 level are strongly correlated with survival and clinical responsiveness to chemotherapy in ovarian cancer
    • Raspollini M.R., Amunni G., Villanucci A., et al. COX-2 and preoperative CA-125 level are strongly correlated with survival and clinical responsiveness to chemotherapy in ovarian cancer. Acta Obstet Gynecol Scand 85 (2006) 493-498
    • (2006) Acta Obstet Gynecol Scand , vol.85 , pp. 493-498
    • Raspollini, M.R.1    Amunni, G.2    Villanucci, A.3
  • 3
    • 1342300679 scopus 로고    scopus 로고
    • Expression of inducible nitric oxide synthase and cyclooxygenase-2 in ovarian cancer: correlation with clinical outcome
    • Raspollini M.R., Amunni G., Villanucci A., et al. Expression of inducible nitric oxide synthase and cyclooxygenase-2 in ovarian cancer: correlation with clinical outcome. Gynecol Oncol 92 (2004) 806-812
    • (2004) Gynecol Oncol , vol.92 , pp. 806-812
    • Raspollini, M.R.1    Amunni, G.2    Villanucci, A.3
  • 4
    • 17344385880 scopus 로고    scopus 로고
    • Clinical trials of newer regimens for treating ovarian cancer: the rationale for Gynecologic Oncology Group Protocol GOG 182-ICON5
    • Copeland L.J., Bookman M., and Trimble E. Clinical trials of newer regimens for treating ovarian cancer: the rationale for Gynecologic Oncology Group Protocol GOG 182-ICON5. Gynecol Oncol 90 (2003) S1-S7
    • (2003) Gynecol Oncol , vol.90
    • Copeland, L.J.1    Bookman, M.2    Trimble, E.3
  • 5
    • 0043234492 scopus 로고    scopus 로고
    • First-line treatment regimens and the role of consolidation therapy in advanced ovarian cancer
    • Stuart G.C.E. First-line treatment regimens and the role of consolidation therapy in advanced ovarian cancer. Gynecol Oncol 90 (2003) S8-S15
    • (2003) Gynecol Oncol , vol.90
    • Stuart, G.C.E.1

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.